Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients P. Akyol, A. Yıldız, M. Albayrak, H. Afacan Öztürk, S. Maral, M. Reis Aras, F. YıLmaz, B. Saglam, M. Tıglıoglu, U. Malkan

CLINICAL, CYTOGENETIC AND MOLECULAR CHARACTERIZATION OF BRAZILIAN COHORT PATIENTS WITH PRIMERY MYELOFIBROSIS AND MYELOFIBROSIS POST-POLYCYTTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA RS Tavares, NCD Clementino, MRM Conchon, KBB Pagnano, SA Santana, ACKVD Nascimento, VAM Funke, RT Centrone, FS Seguro, JAP Bortolini, DA Silveira, I Bendit

ARACHIDONIC ACID (AA)-DERIVED LIPID MEDIATORS ARE INCREASED IN THE BONE MARROW PLASMA FROM POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA PATIENTS M.C. Cacemiro, J.G. Cominal, L.L. Figueiredo-Pontes, C.A. Sorgi, L.H. Faccioli, F.A. Castro